Inside the Lab

Special Episode: Evolving and Emerging Trends in HER2 Classification and Reporting in Breast Cancer

October 20, 2022 American Society for Clinical Pathology
Inside the Lab
Special Episode: Evolving and Emerging Trends in HER2 Classification and Reporting in Breast Cancer
Show Notes

The emergence of HER2-low therapies for metastatic breast cancer is a paradigm shift in the traditional binary classification of a patient’s HER2 status, creating a need for practice changes in pathology necessitated by the expansion in how HER2-low breast cancer needs to be classified and treated. During this recorded 2022 ASCP Annual Meeting session, a moderated expert faculty panel will discuss evolving and emerging trends in breast cancer classification and reporting across the HER2+ spectrum. They will also discuss how pathologists and laboratory professionals can prepare for HER2-low classification, tracking, and reporting. In addition, they will review some of the current challenges in HER2 testing and explore opportunities to prepare for the future landscape of HER classification in breast cancer.  The activity offers 1.0 CME/CMLE credit.  The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.  

Faculty
Swikrity U. Baskota, MD
Assistant Professor, Department of Pathology, and Cell Biology
Columbia University Irving Medical Center 

Marilyn Bui, MD, PhD
Senior Member and Professor of Pathology
Scientific Director of Analytic Microscopy Core
Program Director of Cytopathology Fellowship
Moffitt Cancer Center & Research Institute 

Mamatha Chivukula, MD, FASCP
Director of Breast Pathology Services and IHC Lab
Mills Peninsula Medical Center, Sutter Health Affiliate 

Joseph Kim, MD, MBA, MPH
President
Q Synthesis 

Credit Designation Statement  The ASCP designates this enduring podcast activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.  ASCP designates this enduring podcast activity for a maximum of 1.0 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.  For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time 

Method of Participation  To complete the activity and receive credit, the participant must complete the podcast activity. CME certificates will be provided on-line.  

Commercial Support 

Funded by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.

Provided by the American Society for Clinical Pathology in partnership with Q Synthesis.